Skip to Main text

Taiwan

Press Release 2018

Select Category
2018/Dec/21
Report on the Nitto ATP Finals Charity Programs
2018/Nov/29
Nitto announces Phase I clinical trial of NBF-006 for the treatment of KRAS driven tumors in advanced cancer patients is allowed to proceed by the FDA
2018/Oct/25
100th anniversary greetings
2018/Oct/22
創立100周年記念企業広告展開のお知らせ
2018/Sep/28
Nitto Supports Reconstruction from the 2018 Hokkaido Eastern Iburi earthquake
2018/Aug/11
滋賀事業所再開のお知らせ
2018/Jul/31
New Drug Application in Japan for Transdermal Patch Formulation of Atypical Antipsychotic LONASEN™
2018/Jul/20
About support for damage of the torrential rains
2018/Jul/18
Onomichi Plant resumed operation
2018/Jul/15
Effects of the Torrential Rains in July 2018 (2nd report)
2018/Jul/09
Effects of the Torrential Rains in July 2018
2018/Jun/21
Nitto’s RO membrane to be used for Singapore’s first dual-mode desalination plant
2018/May/31
Contributing to the Efficient Use of Limited Resources: New Nanofiltration Elements for Oil Field Water Injection (World’s Largest Membrane Area & Flow Rate)
2018/May/15
Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator
2018/Apr/11
Initiatives for an Environmentally Friendly Recycling-Oriented Green Plant
2018/Mar/05
IND application of ND-L02-s0201 allowed to proceed for idiopathic pulmonary fibrosis indication by the FDA
2018/Feb/14
Nitto and Sumitomo Dainippon Pharma Announce Positive Topline Results from Phase 3 Study Evaluating Transdermal Patch Formulation of Atypical Antipsychotic LONASEN™
2018/Jan/25
Nitto Selected as Top 100 Global IP/Patents-Related Innovators for Seven Years in a Row
  • topics
  

Contact Us

Business Hours(Taiwan time)
8:30-17:30 (Except for Sat, Sun, and Holidays)

Related Information

Back to Page Top